Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cetuximab with radiochemotherapy and surgery in rectal cancer
NCT00541112Phase 2Terminated
- Sponsor
- Unicancer
- Start
- Oct 2007
- Primary completion
- Jan 2010
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
Phase 2, open-label trial of cetuximab in rectal cancer, sponsored by Unicancer. Started Oct 2007; status: terminated.
02
Drugs
cetuximab
03
Conditions
rectal cancer
Beyond the preview
Go deeper on NCT00541112.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00541112.